ORISDX

Detect Early, Live Fully

Business Model
B2B
Website
orisdx.com
Total Funding
$4.0M
Last Round
$4.0M SeedJun 2025
Rounds
1

About

OrisDX develops salivary diagnostics to detect disease early and guide people to clinical intervention, beginning with oral cancer. Its Oro Lesion test uses next-generation sequencing and proprietary AI-driven analysis of salivary rinse samples to identify somatic mutations that signal cancer. The Oris Bridge platform lets providers register kits and manage the path from detection toward treatment, supplying genomic insights that complement surgical biopsy. Led by scientific, clinical, and business leaders, OrisDX is committed to improving global access to early detection.

Summary

ORISDX is a Diagnostics company. It has raised $4.0M in total across 1 round, most recently a $4.0M Seed round in Jun 2025. Investors include Revere Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

SeedSeed RoundJun 2025
$4.0M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

ORISDX on Indexed.vc
<a href="https://indexed.vc/companies/orisdx"><img src="https://indexed.vc/api/badge/company/orisdx" alt="ORISDX on Indexed.vc" width="260" height="76" /></a>